News Topic - FDA

Clones' offspring may be in food supply: FDA
Reuters - Food and milk from the offspring of cloned animals may have entered the U.S. food supply, the U.S. government said on Tuesday, but it would be impossible to know because there is no difference between cloned and conventional products.
Yahoo!  –  Sep 2, 2008 9:33 PM [GMT]  ¦  comment?
found in Technology: Science

Introgen shares fall on FDA ruling
WASHINGTON, Sept. 2 (UPI) -- A U.S. Food and Drug Administration rejection of a drug application caused shares in Introgen Therapeutics to plummet Tuesday, analysts said.
United Press International  –  Sep 2, 2008 4:12 PM [GMT]  ¦  comment?
found in Business

Introgen's Advexin Gets FDA Snub
The regulator refused to accept and approval application for the gene therapy cancer drug, dealing a devastating blow to the company.
TheStreet.com  –  Sep 2, 2008 3:15 PM [GMT]  ¦  comment?
found in Business: Investing

Introgen Critically Hurt by FDA Advexin Snub
The regulator refused to accept an approval application for the gene therapy cancer drug, dealing a devastating blow to the company.
TheStreet.com  –  Sep 2, 2008 3:15 PM [GMT]  ¦  comment?
found in Business: Investing

Prescription Drugs, Suicide Connection Studied
Several independent experts say the safety alarms point to a gap in the FDA's knowledge of how drugs affect the brain. Even if medications are intended for physical conditions, some drugs can have unforeseen consequences if they are able to enter brain
Fox News  –  Sep 2, 2008 2:22 PM [GMT]  ¦  comment?
found in Health

FDA investigates suicide risks more drugs
WASHINGTON -- Cody Miller was a high school football player who was allergic to ragweed. Douglas Briggs was a doctor coping with pain from an old back injury.
DelawareOnline.com  –  Sep 1, 2008 08:39 AM [GMT]  ¦  comment?
found in Local: Delaware

Amylin Pharmaceuticals And Eli Lilly Provide Context For FDA Alert For BYETTA
Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Eli Lilly and Company (NYSE: LLY) in a conference call today provided context and additional information regarding the August 18, 2008 U.S. Food and Drug Administration (FDA) update to a prior alert for BYETTA(R) (exenatide) injection referencing pancreatitis. The companies were aware of the pancreatitis cases referenced in the alert, as well as others, and previously reported these cases to the FDA.
Medical News Today  –  Aug 31, 2008 07:00 AM [GMT]  ¦  comment?
found in Health: Diabetes

FDA Grants IND For Pro-Pharmaceuticals' DAVANAT® To Treat Breast Cancer Patient
Pro-Pharmaceuticals, Inc. (Amex: PRW), today announced that the U.S. Food and Drug Administration (FDA) has granted an Investigational New Drug (IND) application for use of DAVANAT® in combination with 5-FU to treat a breast cancer patient at the Brown Cancer Center in Louisville, Kentucky. DAVANAT® also is being administered in Phase II clinical trials for first-line treatment of colorectal and biliary cancer patients.
Medical News Today  –  Aug 30, 2008 09:00 AM [GMT]  ¦  comment?
found in Health: Cancer

FDA's mobile field lab in Salinas to do research
The U.S. Food and Drug Administration has brought a state-of-the-art mobile laboratory to Salinas to conduct field research.
TheCalifornian.com  –  Aug 30, 2008 02:00 AM [GMT]  ¦  comment?
found in Local: California: Monterey

TomoTherapy Receives FDA 510(k) Clearance For TomoDirect™ Radiotherapy Technology
TomoTherapy Incorporated (NASDAQ: TOMO) announced that it has received FDA 510(k) clearance for its TomoDirect™ radiation therapy technology. TomoDirect is an innovative new discrete-angle, sliding-beam delivery mode for the Hi•Art® treatment system.
Medical News Today  –  Aug 29, 2008 10:00 AM [GMT]  ¦  comment?
found in Health: Cancer